Application of stem cell marker CD133 interference nucleic acid to preparation of tumor proliferation restraining preparation
A stem cell marker and nucleic acid interference technology, applied in the field of preparation of adjuvant therapy drugs or reagents for liver cancer, can solve the problems of high and limited mortality of liver cancer, lack of sensitive markers of liver cancer, etc., and achieve the effect of reducing the mortality of liver cancer
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] The magnetic bead sorting method sorted out CD133 in Huh7 and PLC / PRF / 5 liver cancer cells + Liver cancer stem cells, using shCD133-1 and shCD133-2 two shRNAs targeting different sequences of CD133, respectively knocked down the liver cancer cell line Huh7-CD133 + Cells and PLC / PRF / 5-CD133 + The expression of CD133 in the cells was compared with shLacz not targeting any human gene sequence, and the knockdown effect of CD133 and the expression of the cell cycle regulatory protein CyclinD1 were detected by western blot hybridization;
[0029] 1) CD133 was isolated from liver cancer cell line Huh7 and PLC / PRF / 5 magnetic beads + Cells, detection of CD133, Cyclin D1 protein expression after CD133 interference nucleic acid
[0030] 1. CD133 was isolated from liver cancer cell line Huh7 and PLC / PRF / 5 magnetic beads + cell
[0031] In this experiment, human liver cancer cell lines Huh7 and PLC / PRF / 5 were used. The cells were cultured in DMEM medium (Gibco) containing 10% fe...
Embodiment 2
[0049] Liver cancer cell lines Huh7 and PLC / PRF / 5CD133 + After knocking down the expression of CD133 in the cells, the proliferation and self-renewal ability of the cells were detected by cell sphere formation assay
[0050] 2) Liver cancer cell lines Huh7 and PLC / PRF / 5CD133 + Knock down the expression of CD133 in cells to detect the ability of cells to form spheres
[0051] 1. Detection of CD133 knockdown of Huh7 and PLC / PRF / 5CD133 + Experimental process and result analysis of cell spheroidizing ability
[0052] 1) Digest the cells of the control group and the CD133 knockdown group cultured in the above DMEM culture medium with trypsin, and resuspend the cells in DMEM culture medium to a single state; centrifuge at 2000rpm for 5 minutes, and aspirate the supernatant; 2) Add vitamin A-free B27 (Gibco), 100 μg / ml penicillin with 20ng / mL EGF (Chemicon), 20ng / mL FGF-2 (Chemicon), 2μg / mL heparin (Sigma), 1:50 ratio Wash the cells with DMEM / F12 medium (Gibco) of 50 μg / ml strept...
Embodiment 3
[0056] Liver cancer cell lines Huh7 and PLC / PRF / 5CD133 + After knocking down the expression of CD133 in the cells, the tumorigenic ability of the cells was detected by subcutaneous tumorigenesis in nude mice
[0057] 3) Liver cancer cell lines Huh7 and PLC / PRF / 5CD133 + Knock down the expression of CD133 in the cells, and detect the subcutaneous tumorigenesis ability of nude mice
[0058] 1. Detection of CD133 knockdown of Huh7 and PLC / PRF / 5CD133 + Experimental process and result analysis of cell tumor formation in nude mice subcutaneously
[0059] 1) Digest the cells with 0.25% trypsin for 1-2min, and blow the cells with DMEM containing 10% fetal bovine serum
[0060] 2) Centrifuge at 2000rpm for 5min, remove the supernatant, wash the cells 3 times with PBS, centrifuge at 2000rpm for 5min, remove the supernatant;
[0061] 3) resuspend the cells with PBS, and count the number of cells with a cell counter;
[0062] 4) will 10 5 Each cell was diluted to 150 μl with PBS, inj...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com